Skip to main content
Top
Published in: Calcified Tissue International 4/2014

01-10-2014 | Original Research

Lean Mass, Muscle Strength and Gene Expression in Community Dwelling Older Men: Findings from the Hertfordshire Sarcopenia Study (HSS)

Authors: Harnish P. Patel, Nasser Al-Shanti, Lucy C. Davies, Sheila J. Barton, Miranda D. Grounds, Ross L. Tellam, Claire E. Stewart, Cyrus Cooper, Avan Aihie Sayer

Published in: Calcified Tissue International | Issue 4/2014

Login to get access

Abstract

Sarcopenia is associated with adverse health outcomes. This study investigated whether skeletal muscle gene expression was associated with lean mass and grip strength in community-dwelling older men. Utilising a cross-sectional study design, lean muscle mass and grip strength were measured in 88 men aged 68–76 years. Expression profiles of 44 genes implicated in the cellular regulation of skeletal muscle were determined. Serum was analysed for circulating cytokines TNF (tumour necrosis factor), IL-6 (interleukin 6, IFNG (interferon gamma), IL1R1 (interleukin-1 receptor-1). Relationships between skeletal muscle gene expression, circulating cytokines, lean mass and grip strength were examined. Participant groups with higher and lower values of lean muscle mass (n = 18) and strength (n = 20) were used in the analysis of gene expression fold change. Expression of VDR (vitamin D receptor) [fold change (FC) 0.52, standard error for fold change (SE) ± 0.08, p = 0.01] and IFNG mRNA (FC 0.31; SE ± 0.19, p = 0.01) were lower in those with higher lean mass. Expression of IL-6 (FC 0.43; SE ± 0.13, p = 0.02), TNF (FC 0.52; SE ± 0.10, p = 0.02), IL1R1 (FC 0.63; SE ± 0.09, p = 0.04) and MSTN (myostatin) (FC 0.64; SE ± 0.11, p = 0.04) were lower in those with higher grip strength. No other significant changes were observed. Significant negative correlations between serum IL-6 (R = −0.29, p = 0.005), TNF (R = −0.24, p = 0.017) and grip strength were demonstrated. This novel skeletal muscle gene expression study carried out within a well-characterized epidemiological birth cohort has demonstrated that lower expression of VDR and IFNG is associated with higher lean mass, and lower expression of IL-6, TNF, IL1R1 and myostatin is associated with higher grip strength. These findings are consistent with a role of proinflammatory factors in mediating lower muscle strength in community-dwelling older men.
Appendix
Available only for authorised users
Literature
1.
go back to reference Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, Edwards M, Dennison E, Cooper C, Aihie Sayer A (2013) Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 42:378–384PubMedCrossRefPubMedCentral Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, Edwards M, Dennison E, Cooper C, Aihie Sayer A (2013) Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 42:378–384PubMedCrossRefPubMedCentral
2.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423PubMedCrossRefPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423PubMedCrossRefPubMedCentral
3.
go back to reference Newman AB, Haggerty CL, Goodpaster B, Harris T, Kritchevsky S, Nevitt M, Miles TP, Visser M (2003) Strength and muscle quality in a well-functioning cohort of older adults: The Health, Aging and Body Composition Study. J Am Geriatr Soc 51:323–330PubMedCrossRef Newman AB, Haggerty CL, Goodpaster B, Harris T, Kritchevsky S, Nevitt M, Miles TP, Visser M (2003) Strength and muscle quality in a well-functioning cohort of older adults: The Health, Aging and Body Composition Study. J Am Geriatr Soc 51:323–330PubMedCrossRef
4.
go back to reference Grounds MD (2002) Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology 3:19–24PubMedCrossRef Grounds MD (2002) Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology 3:19–24PubMedCrossRef
6.
go back to reference Goodman CA, Mayhew DL, Hornberger TA (2011) Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass. Cell Signal 23:1896–1906PubMedCrossRefPubMedCentral Goodman CA, Mayhew DL, Hornberger TA (2011) Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass. Cell Signal 23:1896–1906PubMedCrossRefPubMedCentral
7.
go back to reference Roubenoff R, Parise H, Payette HA, Abad LW, D’Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study. Am J Med 115:429–435PubMedCrossRef Roubenoff R, Parise H, Payette HA, Abad LW, D’Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study. Am J Med 115:429–435PubMedCrossRef
9.
go back to reference Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, Pittas AG, Boland R, Ferrucci L, Bikle DD (2013) Vitamin D: beyond bone. Ann N Y Acad Sci 1287:45–58PubMedCrossRefPubMedCentral Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, Pittas AG, Boland R, Ferrucci L, Bikle DD (2013) Vitamin D: beyond bone. Ann N Y Acad Sci 1287:45–58PubMedCrossRefPubMedCentral
10.
go back to reference Huang Z, Chen X, Chen D (2011) Myostatin:a novel insight into its role in metabolism, signal pathways and expression regulation. Cell Signall 23:1441–1446CrossRef Huang Z, Chen X, Chen D (2011) Myostatin:a novel insight into its role in metabolism, signal pathways and expression regulation. Cell Signall 23:1441–1446CrossRef
12.
go back to reference Boland RL (2011) VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol 347:11–16PubMedCrossRef Boland RL (2011) VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol 347:11–16PubMedCrossRef
13.
go back to reference Ceglia L (2008) Vitamin D and skeletal muscle tissue and function. Mol Asp Med 29:407–414CrossRef Ceglia L (2008) Vitamin D and skeletal muscle tissue and function. Mol Asp Med 29:407–414CrossRef
14.
go back to reference Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144:5138–5144PubMedCrossRef Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144:5138–5144PubMedCrossRef
15.
go back to reference Song Y, Kato S, Fleet JC (2003) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133:374–380PubMed Song Y, Kato S, Fleet JC (2003) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133:374–380PubMed
16.
go back to reference Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE (2004) Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 59:10–15PubMedCrossRef Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE (2004) Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 59:10–15PubMedCrossRef
17.
go back to reference McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83–90PubMedCrossRef McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83–90PubMedCrossRef
18.
go back to reference Kambadur R, Sharma M, Smith TP, Bass JJ (1997) Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7:910–916PubMed Kambadur R, Sharma M, Smith TP, Bass JJ (1997) Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7:910–916PubMed
19.
go back to reference Constantin D, McCullough J, Mahajan RP, Greenhaff PL (2011) Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 589:3883–3895PubMedPubMedCentral Constantin D, McCullough J, Mahajan RP, Greenhaff PL (2011) Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 589:3883–3895PubMedPubMedCentral
20.
go back to reference Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, Bhasin S (1998) Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 95:14938–14943PubMedCrossRefPubMedCentral Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, Bhasin S (1998) Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 95:14938–14943PubMedCrossRefPubMedCentral
21.
go back to reference Allen DL, Loh AS (2011) Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol 300:C124–C137PubMedCrossRefPubMedCentral Allen DL, Loh AS (2011) Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol 300:C124–C137PubMedCrossRefPubMedCentral
22.
go back to reference Lokireddy S, Wijesoma IW, Bonala S, Wei M, Sze SK, McFarlane C, Kambadur R, Sharma M (2012) Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem J 446:23–36PubMedCrossRefPubMedCentral Lokireddy S, Wijesoma IW, Bonala S, Wei M, Sze SK, McFarlane C, Kambadur R, Sharma M (2012) Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem J 446:23–36PubMedCrossRefPubMedCentral
23.
go back to reference Beyer I, Mets T, Bautmans I (2012) Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 15:12–22PubMedCrossRef Beyer I, Mets T, Bautmans I (2012) Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 15:12–22PubMedCrossRef
24.
go back to reference Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64:1183–1189PubMedCrossRef Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64:1183–1189PubMedCrossRef
25.
go back to reference Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326–M332PubMedCrossRef Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326–M332PubMedCrossRef
26.
go back to reference Barns M, Gondro C, Tellam RL, Radley-Crabb HG, Grounds MD, Shavlakadze T (2014) Molecular analyses provide insight into mechanisms underlying sarcopenia and myofiber denervation in old skeletal muscles of mice. Int J Biochem Cell Biol 13(53C):174–185CrossRef Barns M, Gondro C, Tellam RL, Radley-Crabb HG, Grounds MD, Shavlakadze T (2014) Molecular analyses provide insight into mechanisms underlying sarcopenia and myofiber denervation in old skeletal muscles of mice. Int J Biochem Cell Biol 13(53C):174–185CrossRef
27.
go back to reference Liu D, Sartor MA, Nader GA, Pistilli EE, Tanton L, Lilly C, Gutmann L, IglayReger HB, Visich PS, Hoffman EP, Gordon PM (2013) Microarray analysis reveals novel features of the muscle aging process in men and women. J Gerontol A Biol Sci Med Sci 68:1035–1044PubMedCrossRefPubMedCentral Liu D, Sartor MA, Nader GA, Pistilli EE, Tanton L, Lilly C, Gutmann L, IglayReger HB, Visich PS, Hoffman EP, Gordon PM (2013) Microarray analysis reveals novel features of the muscle aging process in men and women. J Gerontol A Biol Sci Med Sci 68:1035–1044PubMedCrossRefPubMedCentral
28.
29.
go back to reference Syddall HE, Sayer AA, Dennison EM, Martin HJ, Barker DJ, Cooper C (2005) Cohort profile: The Hertfordshire cohort study. Int J Epidemiol 34:1234–1242PubMedCrossRef Syddall HE, Sayer AA, Dennison EM, Martin HJ, Barker DJ, Cooper C (2005) Cohort profile: The Hertfordshire cohort study. Int J Epidemiol 34:1234–1242PubMedCrossRef
30.
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef
31.
go back to reference Tichopad A, Pecen L, Pfaffl MW (2006) Distribution-insensitive cluster analysis in SAS on real-time PCR gene expression data of steadily expressed genes. Comput Methods Progr Biomed 82:44–50CrossRef Tichopad A, Pecen L, Pfaffl MW (2006) Distribution-insensitive cluster analysis in SAS on real-time PCR gene expression data of steadily expressed genes. Comput Methods Progr Biomed 82:44–50CrossRef
32.
go back to reference Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC, Lempicki RA (2007) DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35:W169–W175CrossRefPubMedCentral Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC, Lempicki RA (2007) DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35:W169–W175CrossRefPubMedCentral
33.
go back to reference Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059–1064PubMedCrossRef Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059–1064PubMedCrossRef
34.
go back to reference Leger B, Derave W, De BK, Hespel P, Russell AP (2008) Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res 11:163–175BPubMedCrossRef Leger B, Derave W, De BK, Hespel P, Russell AP (2008) Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res 11:163–175BPubMedCrossRef
35.
go back to reference Rieu I, Magne H, Savary-Auzeloux I, Averous J, Bos C, Peyron MA, Combaret L, Dardevet D (2009) Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol 587:5483–5492PubMedCrossRefPubMedCentral Rieu I, Magne H, Savary-Auzeloux I, Averous J, Bos C, Peyron MA, Combaret L, Dardevet D (2009) Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol 587:5483–5492PubMedCrossRefPubMedCentral
36.
go back to reference Bartali B, Frongillo EA, Stipanuk MH, Bandinelli S, Salvini S, Palli D, Morais JA, Volpato S, Guralnik JM, Ferrucci L (2012) Protein intake and muscle strength in older persons: does inflammation matter? J Am Geriatr Soc 60:480–484PubMedCrossRefPubMedCentral Bartali B, Frongillo EA, Stipanuk MH, Bandinelli S, Salvini S, Palli D, Morais JA, Volpato S, Guralnik JM, Ferrucci L (2012) Protein intake and muscle strength in older persons: does inflammation matter? J Am Geriatr Soc 60:480–484PubMedCrossRefPubMedCentral
37.
go back to reference Londhe P, Davie JK (2011) Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA. Mol Cell Biol 31:2854–2866PubMedCrossRefPubMedCentral Londhe P, Davie JK (2011) Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA. Mol Cell Biol 31:2854–2866PubMedCrossRefPubMedCentral
38.
go back to reference Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189PubMedCrossRef Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189PubMedCrossRef
39.
go back to reference Cheng M, Nguyen MH, Fantuzzi G, Koh TJ (2008) Endogenous interferon-gamma is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol 294:C1183–C1191PubMedCrossRef Cheng M, Nguyen MH, Fantuzzi G, Koh TJ (2008) Endogenous interferon-gamma is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol 294:C1183–C1191PubMedCrossRef
40.
go back to reference Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J (2008) Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63:100–107PubMedCrossRef Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J (2008) Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63:100–107PubMedCrossRef
41.
go back to reference Rayavarapu S, Coley W, Nagaraju K (2011) An update on pathogenic mechanisms of inflammatory myopathies. Curr Opin Rheumatol 23:579–584PubMedCrossRef Rayavarapu S, Coley W, Nagaraju K (2011) An update on pathogenic mechanisms of inflammatory myopathies. Curr Opin Rheumatol 23:579–584PubMedCrossRef
42.
go back to reference Crescioli C, Sottili M, Bonini P, Cosmi L, Chiarugi P, Romagnani P, Vannelli GB, Colletti M, Isidori AM, Serio M, Lenzi A, Di LL (2012) Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. Eur J Cell Biol 91:139–149PubMedCrossRef Crescioli C, Sottili M, Bonini P, Cosmi L, Chiarugi P, Romagnani P, Vannelli GB, Colletti M, Isidori AM, Serio M, Lenzi A, Di LL (2012) Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. Eur J Cell Biol 91:139–149PubMedCrossRef
43.
go back to reference Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG (2011) Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124:1838–1847PubMedCrossRefPubMedCentral Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG (2011) Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124:1838–1847PubMedCrossRefPubMedCentral
44.
go back to reference Han DS, Chen YM, Lin SY, Chang HH, Huang TM, Chi YC, Yang WS (2011) Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clin Endocrinol (Oxf) 75:857–863CrossRef Han DS, Chen YM, Lin SY, Chang HH, Huang TM, Chi YC, Yang WS (2011) Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clin Endocrinol (Oxf) 75:857–863CrossRef
45.
go back to reference Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O’Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM (2003) Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300:965–971PubMedCrossRef Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O’Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM (2003) Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300:965–971PubMedCrossRef
46.
go back to reference Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K (2007) Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A 104:1835–1840PubMedCrossRefPubMedCentral Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K (2007) Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A 104:1835–1840PubMedCrossRefPubMedCentral
47.
go back to reference Schirwis E, Agbulut O, Vadrot N, Mouisel E, Hourde C, Bonnieu A, Butler-Browne G, Amthor H, Ferry A (2012) The beneficial effect of myostatin deficiency on maximal muscle force and power is attenuated with age. Exp Gerontol 48(2):183–190PubMedCrossRef Schirwis E, Agbulut O, Vadrot N, Mouisel E, Hourde C, Bonnieu A, Butler-Browne G, Amthor H, Ferry A (2012) The beneficial effect of myostatin deficiency on maximal muscle force and power is attenuated with age. Exp Gerontol 48(2):183–190PubMedCrossRef
Metadata
Title
Lean Mass, Muscle Strength and Gene Expression in Community Dwelling Older Men: Findings from the Hertfordshire Sarcopenia Study (HSS)
Authors
Harnish P. Patel
Nasser Al-Shanti
Lucy C. Davies
Sheila J. Barton
Miranda D. Grounds
Ross L. Tellam
Claire E. Stewart
Cyrus Cooper
Avan Aihie Sayer
Publication date
01-10-2014
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2014
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-014-9894-z

Other articles of this Issue 4/2014

Calcified Tissue International 4/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.